Loading...
Chemical structure of Rislenemdaz

GC30835

Rislenemdaz

Also listed as Rislenemdaz (MK-0657)

Rislenemdaz (MK-0657) (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC 50 of 8·1 nM and 3·6 nM, respectively

ChemicalCAS808732-98-1MW358.41FormulaC19H23FN4O2
CAS number
808732-98-1
Molecular weight
358.41
Formula
C19H23FN4O2
Solubility
DMSO ： 150 mg/mL (418·52 mM)
InChIKey
RECBFDWSXWAXHY-IAGOWNOFSA-N
Catalogue number
GC30835
Brand
GLPBIO
Computed properties PubChem CID 11394238 · XLogP 3.1 · TPSA 67.4 Ų · H-bond donors 1
XLogP
3.1
TPSA
67.4 Ų
H-bond donors
1
H-bond acceptors
6
Rotatable bonds
6
Heavy atoms
26

SMILES CC1=CC=C(C=C1)COC(=O)N2CC[C@@H]([C@@H](C2)F)CNC3=NC=CC=N3

Computed descriptors from PubChem (CID 11394238), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.